Inventor
BHYRAPUNENI GOPINADH
IN13 patents
⚠️ This page may combine multiple inventors who share the name “BHYRAPUNENI GOPINADH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUVEN LIFE SCIENCES LTD
9 patentsUS9957257B2May 1, 2018
Amide compounds as 5-HT4 receptor agonists
SUVEN LIFE SCIENCES LTD12 citations81
US11458135B2Oct 4, 2022
Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors
SUVEN LIFE SCIENCES LTD0 citations61
US11253514B2Feb 22, 2022
Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist
SUVEN LIFE SCIENCES LTD0 citations61
US11116764B2Sep 14, 2021
Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist
SUVEN LIFE SCIENCES LTD0 citations61
US11040026B2Jun 22, 2021
Muscarinic M1 receptor positive allosteric modulators
SUVEN LIFE SCIENCES LTD1 citations60
US10294217B2May 21, 2019
Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators
SUVEN LIFE SCIENCES LTD1 citations60
US12285421B2Apr 29, 2025
Uses of a 5-HT4 receptor agonist
SUVEN LIFE SCIENCES LTD0 citations57
US10603323B2Mar 31, 2020
Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors
SUVEN LIFE SCIENCES LTD0 citations51
US9636335B2May 2, 2017
Heteroaryl compounds as 5-HT4 receptor ligands
SUVEN LIFE SCIENCES LTD1 citations48
NIROGI RAMAKRISHNA
4 patentsUS9079894B2Jul 14, 2015
Heteroaryl compounds as 5-HT4 receptor ligands
NIROGI RAMAKRISHNA5 citations68
US8735423B2May 27, 2014
Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligands
NIROGI RAMAKRISHNA2 citations57
US8404720B2Mar 26, 2013
Aryl sulfonamide amine compounds and their use as 5-HT6 ligands
NIROGI RAMAKRISHNA0 citations51
US8598204B2Dec 3, 2013
1,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligands
NIROGI RAMAKRISHNA0 citations49